Living Donor Renal Transplantation Using Alemtuzumab Induction and Tacrolimus Monotherapy

Alemtuzumab was used as an induction agent in 205 renal transplant recipients undergoing 207 living donor renal transplants. All donor kidneys were recovered laparoscopically. Postoperatively, patients were treated with tacrolimus monotherapy, and immunosuppression was weaned when possible. Forty-se...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tan, H. P., Kaczorowski, D. J., Basu, A., Unruh, M., McCauley, J., Wu, C., Donaldson, J., Dvorchik, I., Kayler, L., Marcos, A., Randhawa, P., Smetanka, C., Starzl, T. E., Shapiro, R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2006
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3154761/
https://ncbi.nlm.nih.gov/pubmed/16889606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-6143.2006.01495.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados